Actively Recruiting
Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children
Led by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Updated on 2023-07-10
34
Participants Needed
1
Research Sites
187 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare the control group treated with stroid to see if the efficacy of Leflunomide would be better than control group.
CONDITIONS
Official Title
Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age range from 6 months to 18 years old
- Diagnosed with Idiopathic Pulmonary Hemosiderosis (IPH)
- Parents or guardians agree to treatment and sign a written informed consent form
You will not qualify if you...
- Allergy to any ingredients in leflunomide tablets
- Serious underlying diseases such as systemic malignancy, heart failure, liver or kidney failure, immune deficiency, serious infections, lung transplantation, or immediate surgical indication
- Presence of other lung diseases
- History of abnormal coagulation or coagulation dysfunction
- Previous participation in clinical trials involving flumiphene treatment
- Any other condition deemed inappropriate for study participation by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510120
Actively Recruiting
Research Team
H
Haiyan Wang, MD
CONTACT
W
Weiping Tan, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here